BioCentury
ARTICLE | Company News

ElexoPharm, SomantiX B.V., PharmBioTec GmbH, Saarland University, VU University Medical Center cancer news

October 22, 2012 7:00 AM UTC

EuroTransBio awarded a three-year grant worth €1.5 million ($1.9 million) to a consortium to develop low molecular weight inhibitors of angiogenesis in colorectal cancer. ElexoPharm will lead discover...